Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro.

Hori, K; Hatfield, D; Maldarelli, F; Lee, B J; Clouse, K A

Hori, K; Hatfield, D; Maldarelli, F; Lee, B J; Clouse, K A.

Affiliation

Hori K; Division of Cytokine Biology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA.

AIDS Res Hum Retroviruses ; 13(15): 1325-32, 1997 Oct 10.

Article in En | MEDLINE | ID: mdl-9339849

Subject(s)

HIV Infections/metabolism; HIV-1/growth & development; Selenium/pharmacology; Tumor Necrosis Factor-alpha/pharmacology; Virus Replication/drug effects; Cells, Cultured; Glutathione Peroxidase/metabolism; HIV Infections/immunology; HIV Infections/virology; HIV Reverse Transcriptase/metabolism; HIV Seronegativity; Humans; Monocytes/virology; Proteins/metabolism; Selenoproteins; T-Lymphocytes/virology; Thioredoxin-Disulfide Reductase/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Selenium / Virus Replication / HIV Infections / HIV-1 / Tumor Necrosis Factor-alpha Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links